FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2913989431> ?p ?o ?g. }

• W2913989431 endingPage "99" @default.
• W2913989431 startingPage "92" @default.
• W2913989431 abstract "Background and aims Despite the advantage of arterial expansion for life-threatening vascular pathologies, the occurrence of neointima formation remains a prominent complication, with the underlying mechanisms largely unknown. A disintegrin and metalloprotease 22 (ADAM22) belongs to the family of ADAMs that possesses various biological capacities regulating vascular physiopathology. However, little is known about ADAM22 in vascular smooth muscle cell (VSMC)-mediated neointima formation. Here, we aimed to evaluate the potential functional regulation of ADAM22 in neointima formation and to further explore the underlying mechanisms. Methods In our study, platelet-derived growth factor-BB (PDGF-BB)-induced VSMC proliferation was examined using a 5-bromo-2′-deoxyuridine (BrdU) incorporation assay and a cell counting kit-8 (CCK8) assay, while VSMC migration was detected using a modified Boyden chamber method and a scratch-wound assay. The functional role of ADAM22 in neointima formation was evaluated based on a left carotid artery wire injury model in mice at 14 and 28 days. Results ADAM22 was significantly up-regulated in both PDGF-BB-challenged VSMCs and restenotic arteries of mice. When ADAM22 was overexpressed in VSMCs, cell proliferation, migration and phenotypic switching were simultaneously aggravated, whereas the opposite was observed when ADAM22 was knocked down in vitro. In ADAM22 heterozygote mice, wire-injury induced neointima formation was significantly ameliorated compared to wild-type control mice. Mechanistically, significantly up-regulated ERK phosphorylation is closely involved in the regulatory effects of ADAM22 in neointima formation. Interestingly, an ERK inhibitor largely reversed the aggravated VSMCs migration, proliferation and phenotypic switching induced by ADAM22 overexpression. Conclusions Our results indicate that ADAM22 accelerates neointima formation by enhancing VSMC migration, proliferation and phenotypic switching via promoting ERK phosphorylation. Suppressing ADAM22 expression may be an effective strategy for ameliorating neointima formation." @default.
• W2913989431 created "2019-02-21" @default.
• W2913989431 creator A5009679536 @default.
• W2913989431 creator A5012267050 @default.
• W2913989431 creator A5027931938 @default.
• W2913989431 creator A5036881486 @default.
• W2913989431 creator A5040303259 @default.
• W2913989431 creator A5043029830 @default.
• W2913989431 creator A5066399940 @default.
• W2913989431 creator A5068607834 @default.
• W2913989431 date "2019-04-01" @default.
• W2913989431 modified "2023-10-15" @default.
• W2913989431 title "A disintegrin and metalloprotease 22 accelerates neointima formation by activating ERK signaling" @default.
• W2913989431 cites W1756962622 @default.
• W2913989431 cites W1813615729 @default.
• W2913989431 cites W1872393578 @default.
• W2913989431 cites W1912592877 @default.
• W2913989431 cites W1976921095 @default.
• W2913989431 cites W1987430295 @default.
• W2913989431 cites W1992398154 @default.
• W2913989431 cites W1997044589 @default.
• W2913989431 cites W1999182913 @default.
• W2913989431 cites W2001793664 @default.
• W2913989431 cites W2004349592 @default.
• W2913989431 cites W2010257803 @default.
• W2913989431 cites W2012470143 @default.
• W2913989431 cites W2013535701 @default.
• W2913989431 cites W2037630194 @default.
• W2913989431 cites W2047746337 @default.
• W2913989431 cites W2057474081 @default.
• W2913989431 cites W2063277519 @default.
• W2913989431 cites W2071637341 @default.
• W2913989431 cites W2072440487 @default.
• W2913989431 cites W2073373394 @default.
• W2913989431 cites W2078391868 @default.
• W2913989431 cites W2092282197 @default.
• W2913989431 cites W2100168858 @default.
• W2913989431 cites W2107038880 @default.
• W2913989431 cites W2107505404 @default.
• W2913989431 cites W2118845921 @default.
• W2913989431 cites W2143241095 @default.
• W2913989431 cites W2145837099 @default.
• W2913989431 cites W2149152049 @default.
• W2913989431 cites W2149172274 @default.
• W2913989431 cites W2149847331 @default.
• W2913989431 cites W2150675666 @default.
• W2913989431 cites W2162841970 @default.
• W2913989431 cites W2167903579 @default.
• W2913989431 cites W2172072379 @default.
• W2913989431 cites W2338785315 @default.
• W2913989431 cites W2752663541 @default.
• W2913989431 cites W2794346569 @default.
• W2913989431 doi "https://doi.org/10.1016/j.atherosclerosis.2019.02.002" @default.
• W2913989431 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30822685" @default.
• W2913989431 hasPublicationYear "2019" @default.
• W2913989431 type Work @default.
• W2913989431 sameAs 2913989431 @default.
• W2913989431 citedByCount "4" @default.
• W2913989431 countsByYear W29139894312022 @default.
• W2913989431 countsByYear W29139894312023 @default.
• W2913989431 crossrefType "journal-article" @default.
• W2913989431 hasAuthorship W2913989431A5009679536 @default.
• W2913989431 hasAuthorship W2913989431A5012267050 @default.
• W2913989431 hasAuthorship W2913989431A5027931938 @default.
• W2913989431 hasAuthorship W2913989431A5036881486 @default.
• W2913989431 hasAuthorship W2913989431A5040303259 @default.
• W2913989431 hasAuthorship W2913989431A5043029830 @default.
• W2913989431 hasAuthorship W2913989431A5066399940 @default.
• W2913989431 hasAuthorship W2913989431A5068607834 @default.
• W2913989431 hasConcept C109523444 @default.
• W2913989431 hasConcept C126322002 @default.
• W2913989431 hasConcept C185592680 @default.
• W2913989431 hasConcept C2777339539 @default.
• W2913989431 hasConcept C2778259572 @default.
• W2913989431 hasConcept C2778283817 @default.
• W2913989431 hasConcept C2778583881 @default.
• W2913989431 hasConcept C2779395532 @default.
• W2913989431 hasConcept C2992686903 @default.
• W2913989431 hasConcept C55493867 @default.
• W2913989431 hasConcept C55728118 @default.
• W2913989431 hasConcept C57074206 @default.
• W2913989431 hasConcept C62112901 @default.
• W2913989431 hasConcept C62478195 @default.
• W2913989431 hasConcept C71924100 @default.
• W2913989431 hasConcept C86803240 @default.
• W2913989431 hasConcept C95444343 @default.
• W2913989431 hasConceptScore W2913989431C109523444 @default.
• W2913989431 hasConceptScore W2913989431C126322002 @default.
• W2913989431 hasConceptScore W2913989431C185592680 @default.
• W2913989431 hasConceptScore W2913989431C2777339539 @default.
• W2913989431 hasConceptScore W2913989431C2778259572 @default.
• W2913989431 hasConceptScore W2913989431C2778283817 @default.
• W2913989431 hasConceptScore W2913989431C2778583881 @default.
• W2913989431 hasConceptScore W2913989431C2779395532 @default.
• W2913989431 hasConceptScore W2913989431C2992686903 @default.
• W2913989431 hasConceptScore W2913989431C55493867 @default.
• W2913989431 hasConceptScore W2913989431C55728118 @default.
• W2913989431 hasConceptScore W2913989431C57074206 @default.

• next